Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
12810.67%
↑ 2398% vs avg
Percentile
P100
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
512.79%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 12810.67% |
| Q2 2025 | -109.55% |
| Q1 2025 | 24.97% |
| Q4 2024 | -11.85% |
| Q3 2024 | 155.40% |
| Q2 2024 | 56.56% |
| Q1 2024 | -737.87% |
| Q4 2023 | 114.02% |
| Q3 2023 | -5.12% |
| Q2 2023 | -689.36% |
| Q1 2023 | 117.69% |
| Q4 2022 | -10.57% |
| Q3 2022 | -12.77% |
| Q2 2022 | -2005.46% |
| Q1 2022 | -96.98% |
| Q4 2021 | 333.11% |
| Q3 2021 | -7.04% |
| Q2 2021 | -116.45% |
| Q1 2021 | 0.00% |
| Q4 2020 | -100.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 100.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | -100.00% |
| Q1 2017 | -48.48% |
| Q4 2016 | -97.12% |
| Q3 2016 | 10242.96% |
| Q2 2016 | 20.96% |
| Q1 2016 | -59.47% |
| Q4 2015 | 743.28% |